CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (unaudited) - USD ($) $ in Thousands	Total	Common Stock	Treasury Stock, Common	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss	Adjustment	Adjustment Additional Paid-in Capital	Adjustment Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021		74,980,546	(2,746,243)
Beginning balance at Dec. 31, 2021	$ 349,437	$ 75	$ (3)	$ 871,788	$ (516,859)	$ (5,564)
Beginning balance (Accounting Standards Update 2020-06) at Dec. 31, 2021							$ (159,407)	$ (209,651)	$ 50,244
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting Standards Update [Extensible Enumeration]	Accounting Standards Update 2020-06
Common stock issued upon exercise of stock options (in shares)		40,483
Common stock issued upon exercise of stock options	$ 506			506
Common stock issued upon vesting of restricted stock units	0
Common stock issued upon vesting of restricted stock units (in shares)		444,043
Stock-based compensation	20,522			20,522
Cash awards settled in shares of the Company’s common stock	17,299	$ 1		17,298
Cash awards settled in shares of the company's common stock (in shares)		735,519
Common stock issued under Employee Stock Purchase Plan (ESPP)	1,415			1,415
Common stock issued under Employee Stock Purchase Plan (in shares)		82,100
Issuance of common stock in connection with acquisitions (Note 9)	17,637	$ 1		17,636
Issuance of common stock in connection with acquisitions (in shares)		779,946
Net loss	(65,364)				(65,364)
Other comprehensive income	(1,699)					(1,699)
Ending balance at Mar. 31, 2022	180,346	$ 77	$ (3)	719,514	(531,979)	(7,263)
Ending balance (in shares) at Mar. 31, 2022		77,062,637	(2,746,243)
Beginning balance (in shares) at Dec. 31, 2021		74,980,546	(2,746,243)
Beginning balance at Dec. 31, 2021	349,437	$ 75	$ (3)	871,788	(516,859)	(5,564)
Beginning balance (Accounting Standards Update 2020-06) at Dec. 31, 2021							$ (159,407)	$ (209,651)	$ 50,244
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cash awards settled in shares of the Company’s common stock	17,298
Net loss	(184,023)
Ending balance at Sep. 30, 2022	89,511	$ 78	$ (3)	757,162	(650,638)	(17,088)
Ending balance (in shares) at Sep. 30, 2022		77,934,440	(2,746,243)
Beginning balance (in shares) at Mar. 31, 2022		77,062,637	(2,746,243)
Beginning balance at Mar. 31, 2022	180,346	$ 77	$ (3)	719,514	(531,979)	(7,263)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued upon exercise of stock options (in shares)		25,295
Common stock issued upon exercise of stock options	389			389
Common stock issued upon vesting of restricted stock units	1	$ 1
Common stock issued upon vesting of restricted stock units (in shares)		372,500
Stock-based compensation	18,826			18,826
Common stock issued under Employee Stock Purchase Plan (ESPP)	1,403			1,403
Common stock issued under Employee Stock Purchase Plan (in shares)		99,495
Net loss	(75,411)				(75,411)
Other comprehensive income	(4,799)					(4,799)
Ending balance at Jun. 30, 2022	120,755	$ 78	$ (3)	740,132	(607,390)	(12,062)
Ending balance (in shares) at Jun. 30, 2022		77,559,927	(2,746,243)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued upon exercise of stock options (in shares)		134,423
Common stock issued upon exercise of stock options	343			343
Common stock issued upon vesting of restricted stock units	0
Common stock issued upon vesting of restricted stock units (in shares)		161,272
Stock-based compensation	15,843			15,843
Common stock issued under Employee Stock Purchase Plan (ESPP)	844			844
Common stock issued under Employee Stock Purchase Plan (in shares)		78,818
Net loss	(43,248)				(43,248)
Other comprehensive income	(5,026)					(5,026)
Ending balance at Sep. 30, 2022	89,511	$ 78	$ (3)	757,162	(650,638)	(17,088)
Ending balance (in shares) at Sep. 30, 2022		77,934,440	(2,746,243)
Beginning balance (in shares) at Dec. 31, 2022		78,350,984	(2,766,073)
Beginning balance at Dec. 31, 2022	68,088	$ 78	$ (3)	771,052	(692,362)	(10,677)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued upon exercise of stock options (in shares)		18,687
Common stock issued upon exercise of stock options	130			130
Common stock issued upon vesting of restricted stock units	1	$ 1
Common stock issued upon vesting of restricted stock units (in shares)		413,252
Stock-based compensation	9,560			9,560
Common stock issued under Employee Stock Purchase Plan (ESPP)	724			724
Common stock issued under Employee Stock Purchase Plan (in shares)		87,794
Issuance of common stock in connection with acquisitions (Note 9)	380			380
Activity related to divestiture (Note 20)	2,732			66,775	(64,100)	57
Net loss	(17,420)				(17,420)
Other comprehensive income	809					809
Ending balance at Mar. 31, 2023	65,004	$ 79	$ (3)	848,621	(773,882)	(9,811)
Ending balance (in shares) at Mar. 31, 2023		78,870,717	(2,766,073)
Beginning balance (in shares) at Dec. 31, 2022		78,350,984	(2,766,073)
Beginning balance at Dec. 31, 2022	$ 68,088	$ 78	$ (3)	771,052	(692,362)	(10,677)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued upon exercise of stock options (in shares)	48,000
Cash awards settled in shares of the Company’s common stock	$ 0
Net loss	(59,910)
Ending balance at Sep. 30, 2023	45,081	$ 81	$ (3)	872,958	(816,372)	(11,583)
Ending balance (in shares) at Sep. 30, 2023		81,190,765	(2,766,073)
Beginning balance (in shares) at Mar. 31, 2023		78,870,717	(2,766,073)
Beginning balance at Mar. 31, 2023	65,004	$ 79	$ (3)	848,621	(773,882)	(9,811)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued upon exercise of stock options (in shares)		11,154
Common stock issued upon exercise of stock options	8			8
Common stock issued upon vesting of restricted stock units	0
Common stock issued upon vesting of restricted stock units (in shares)		295,564
Stock-based compensation	8,380			8,380
Common stock issued under Employee Stock Purchase Plan (ESPP)	397			397
Common stock issued under Employee Stock Purchase Plan (in shares)		97,832
Issuance of common stock in connection with acquisitions (Note 9)	5,148	$ 1		5,147
Issuance of common stock in connection with acquisitions (in shares)		1,036,823
Net loss	10,822				10,822
Other comprehensive income	386					386
Ending balance at Jun. 30, 2023	90,145	$ 80	$ (3)	862,553	(763,060)	(9,425)
Ending balance (in shares) at Jun. 30, 2023		80,312,090	(2,766,073)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued upon exercise of stock options (in shares)		17,727
Common stock issued upon exercise of stock options	15			15
Common stock issued upon vesting of restricted stock units	2	$ 1		1
Common stock issued upon vesting of restricted stock units (in shares)		588,159
Stock-based compensation	8,849			8,849
Common stock issued under Employee Stock Purchase Plan (ESPP)	348			348
Common stock issued under Employee Stock Purchase Plan (in shares)		82,747
Issuance of common stock in connection with acquisitions (Note 9)	1,192			1,192
Issuance of common stock in connection with acquisitions (in shares)		190,042
Net loss	(53,312)				(53,312)
Other comprehensive income	(2,158)					(2,158)
Ending balance at Sep. 30, 2023	$ 45,081	$ 81	$ (3)	$ 872,958	$ (816,372)	$ (11,583)
Ending balance (in shares) at Sep. 30, 2023		81,190,765	(2,766,073)